Industry Overview

The global prefilled syringes market is expected to grow from USD 8.01 billion in 2025 to USD 16.73 billion by 2035 at a CAGR of 13.08% during the forecast period ranging from 2026 to 2035.

Prefilled syringe refers to a single-use syringe that is filled with drug. These syringes offer significant benefits to the users with the convenience in use. It reduces the chances of medication errors or overdosage. Moreover, patients do not have to undergo through a number of processes required for administering a drug. There are different types of prefilled syringes available in the market that are used for various purposes and determines the market size.  

The factors that drive the growth of the prefilled syringes market include the growing prevalence of chronic diseases. Rapid technological advancements also fuel the market growth, which is further facilitated by the supportive government regulations to promote the use of such syringes. In addition, the rise in healthcare expenditure as well as disposable income, both fuels the growth of the prefilled syringes market. People now use home-use devices more than before.

One of the most significant hindrances to the growth of the prefilled syringes market is the availability of cheaper alternatives. Furthermore, the strict government regulations also prevent widespread adoption of these syringes and pulls back the growth of the market. However, the significant progress in drug delivery technology with needle safety systems and integrated autoinjectors, growing geriatric population and incidents of chronic diseases, developing healthcare infrastructure, and productive collaborations between device manufacturers and healthcare providers drive innovation and presents significant growth avenues.

Market Segmentation

Insight by Material

The global prefilled syringes market is divided by materials into glass and plastic. Out of these two segments, the glass material segment will grow more due to higher preference due to its non-reactive nature. It is also attributed to its higher mechanical strength, heat tolerance, and transparency. On the other hand, the plastic material segment will also grow at a faster rate during the forecast period due to break resistance and lower surface reactivity.

Insight by Type

The global prefilled syringes market is divided by types into safety and conventional segments. The conventional syringe segment will grow more due to rise of chronic diseases, growing adoption of self-administered injectable drug, and the benefits offered over the traditional vial syringe systems.

Insight by Design

The global prefilled syringes market is divided by designs into dual chamber, single chamber and customized segments. Out of these segments, the single chamber prefilled syringes segment will grow more due to growing acceptance of self-administration of parental drug and prevalence of chronic diseases.

Insight by Distribution Channel

The global prefilled syringes market is divided by distribution channels into hospitals, mail order pharmacies, and ambulatory surgery centers. Out of these three segments, the hospitals segment will account for the largest market share due to higher preference by patients seeking treatments due to their convenient accessibility and higher trust. The mail order pharmacies segment will also grow at a higher rate due to the convenience in delivering medications directly to patients’ homes.

Insight by Application

The global prefilled syringes market is divided by application into vaccines & immunizations, anaphylaxis, rheumatoid arthritis, diabetes, autoimmune diseases, oncology, and other segments. Out of all these segments, the vaccines and immunizations segment will account for the largest market share due to better administering of multiple doses over a period of time without requiring drawing medication from vials, lowering risk of contamination and errors. The oncology segment will also grow at the fastest CAGR due to the ease to transport and self-administer.

Global Prefilled Syringes Market Report Coverage

Report Metric	Details
Historical Period	2020 - 2024
Base Year Considered	2025
Forecast Period	2026 - 2035
Market Size in 2025	U.S.D.  8.01 Billion
Revenue Forecast in 2035	U.S.D.  16.73 Billion
Growth Rate	13.08%
Segments Covered in the Report	By Material, By Type, By Design, By Distribution Channel and By Application
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

There is an increased adoption of self-injection devices noticed in the industry. In addition, rapid advancement in technology to develop advanced syringes is also a notable trend in the prefilled syringes market. In addition, the combination therapy is also one of the major trends in the market that have dual or multi chambers to facilitate use of lyophilized drugs. There is an increased focus on patient safety and reduced medication errors which facilitates the use of the prefilled syringes.

Growth Drivers

The rapid growth of aging population is one primary growth factor of the prefilled syringes market due to their higher vulnerability to chronic diseases needing frequent injections devices. It is also attributed to the growing demand for vaccine worldwide to prevent illnesses due to virus attacks. In addition, the large pool of population base and the significant benefits offered by these syringes also surge up the demand for them and propels the market growth, primarily due to the higher inclination towards parental administration, which is the second most widespread mode of drug delivery. Apart from that, the growing demand for self-injection device is also facilitating the growth for the prefilled syringes market mainly due to the lower risk of needlestick injury by these syringes since most of them have retractable needles and a few even lack needles. In addition, these self-injection devices allow more accurate dosage volume, which reduces the wastage of drugs. Also, the growing demand for biosimilars and biologics and the rising shift towards home healthcare are enhancing the market growth.

Challenges

The high cost of these syringes and easy availability of alternative drug delivery methods are the major hindrances for the growth of prefilled syringes market. Some of these methods are oral, infusion, and injections. Out of these methods, the oral delivery method is the most commonly used drug delivery alternative mode worldwide and is a cost-effective method that is very easy to use for patients. In addition, interaction of the plastic material used to make the syringes with the drugs as well as higher product recalls are also significant factors that hinders the growth of the market.

Opportunities

Significant growth opportunities are however offered by the increasing preference among patients for self-administration of drugs at home due to ease of use and convenience. In addition, the expansion of the biopharmaceutical market, growing need to reduce the risk of dosing errors and contamination, supporting regulations to promote adoption, growing disposable income, and market expansion in emerging economies also present novel growth opportunities.

Geographic Overview

Europe is the largest prefilled syringe market and will continue to be the one due to the growing prevalence of chronic diseases, such as diabetes. The rise in healthcare expenditure and easy accessibility and affordability of treatments among individuals also promotes the growth of the European market.

The north American market is also a large contributor to the market due to the growing aging population, significant tech developments, and the growing demand for biosimilars and biologics, as is in the European prefilled syringes market.

The Asia-Pacific market is also expected to grow at a higher rate during the forecast period due to the growing demand for vaccine for the management of rising occurrences of chronic diseases in the region. It is also attributed to the growing use of biologics and biosimilars. In addition, high penetration and usage of self-administration devices and a large population base along with an increasing demand for self-administered treatments are also creating a positive impact on the prefilled syringes market growth in the region.

Competitive Insight

Key players in the prefilled syringes industry are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. According to Unilife Corporation, a company involved in the development, design and production of injectable drug delivery system, approximately 2 billion prefilled syringes are used each year globally. Becton, Dickinson and Company, Weigao Group, Gerresheimer AG, SCHOTT AG, Catalent, Inc., West Pharmaceutical Services, Inc., Ompi, Vetter Pharma International GmbH, Nipro Corporation, and MedPro Inc. are the key players offering prefilled syringes.

Shandong Weigao Group Medical Polymer is a medical device company based out of WEIHAI, SDG, China. The Group focuses on the long-term development of its product brands and emphasizes the quality of its products. Since November 2001, the Group's quality system for the production and service of single-use sterile infusion sets, single-use sterile blood transfusion sets and single-use sterile syringes has been awarded ISO9001:2000 certification and China CMD certification by the China Medical Device Quality Certification Center.

Gerresheimer AG is a German manufacturer of primary packaging products for medication and drug delivery devices made of special-purpose glass and plastics with headquarters in Düsseldorf for the pharmaceutical and cosmetics industries. The company has production operations in Europe, the Americas and Asia.

Recent Developments by Key Players

Gerresheimer Glas GmbH (an indirect subsidiary of Gerresheimer AG) has signed a purchase agreement with funds advised by Triton for the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group.

Gerresheimer Glas GmbH expanded its production capacities for medical systems in the US, with an investment of around Euro 166m. The investment will see the expansion of Gerresheimer’s facility in Peachtree City, Georgia.

Industry Segmentation

The Prefilled Syringes market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Material
  • Glass
  • Plastic
• By Type
  • Safety
  • Conventional
• By Design
  • Dual chamber
  • Single chamber
  • Customized

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

 

Source: VynZ Reseach

Source: VynZ Reseach